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Urbanization and prevalence of type 2 
diabetes in Southern Asia: A systematic 
analysis
Background Diabetes mellitus is one of the diseases considered to be 
the main constituents of the global non–communicable disease 
(NCD) pandemic. Despite the large impact that NCDs are predicted 
to have, particularly in developing countries, estimates of disease bur-
den are sparse and inconsistent. This systematic review transparent-
ly estimates prevalence of type 2 diabetes mellitus in Southern Asia, 
its association with urbanization and provides insight into the policy 
challenges facing the region.
Methods The databases Medline and PubMed were searched for pop-
ulation–based studies providing estimates of diabetes prevalence in the 
Southern Asia region. Studies using WHO diagnostic criteria of fasting 
plasma glucose (FPG) ≥7.0mmol/L and/or 2-hour plasma glucose 
(2hPG) ≥11.1mmol/L were included. Data from eligible studies was 
extracted into bubble graphs, and trend lines were applied to UNPD 
figures to estimate age–specific prevalence in the regional population. 
Estimates specific to sex, area of residency, and diagnostic method were 
compared and trends analysed.
Results A total of 151 age–specific prevalence estimates were extract-
ed from 39 studies. Diabetes prevalence was estimated to be 7.47% 
for 2005 and 7.60% for 2010. Prevalence was strongly associated 
with increased age, male gender and urban residency (P < 0.001).
Conclusion Diabetes prevalence in Southern Asia is high and pre-
dicted to increase in the future as life expectancy rises and the region 
continues to urbanise. Countries in this region need to improve NCD 
surveillance and monitoring so policies can be informed with the best 
evidence. Programs for prevention need to be put in place, and health 
system capacity and access needs to be assessed and increased to deal 
with the predicted rise in NCD prevalence.
Electronic supplementary material:  
The online version of this article contains supplementary material.
In recent years the issue of non–communicable diseases (NCDs) has been 
identified as a pressing concern that has come to the forefront of interna-
tional policy discussion. NCDs are the leading causes of death and dis-
ability worldwide [1]. It was estimated that 33 million deaths in 2008 oc-
curred from NCDs, accounting for almost two–thirds of all deaths for that 
year [2]. In addition, estimates suggest that these may increase further to 
a projected 52 million deaths by 2030, nearly five times as many deaths 
as projected for communicable diseases [3]. Type 2 diabetes mellitus (DM), 
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along with cardiovascular disease, cancers, and chronic re-
spiratory diseases, are considered four primary constituent 
diseases of the global NCD pandemic [3,4]. Importantly, the 
main risk factors for these diseases are modifiable and these 
diseases are heavily influenced by lifestyle and behaviour 
[5]. Shared risk factors between these diseases – such as eat-
ing an unhealthy diet high in saturated fat and sugar, a lack 
of physical activity, and tobacco smoking – account for over 
two–thirds of new NCD cases and increase the risk of exac-
erbations in those who already have these diseases [5]. 
These risk factors and resulting diseases are not limited to 
high–income countries – a disproportionate NCD burden 
is borne by developing countries. Over 80% of diabetes and 
cardiovascular deaths worldwide occur in low– and mid-
dle–income countries (LMICs), and many of the risk factors 
for these NCDs are associated with the country develop-
ment process through globalisation and urbanisation [3]. 
The prevalence of the common NCDs increases with ad-
vancing age, so as life expectancy in LMICs increases the 
burden of NCDs is also expected to rise.
Non–communicable diseases are more likely to affect peo-
ple who are socioeconomically disadvantaged, furthering 
health inequalities [6]. This can be due to contextual factors 
relating to the society and place in which people live in ad-
dition to behavioural factors. In LMICs, diabetes and its risk 
factors are associated with lower education levels [3]. The 
higher burden of NCDs poses additional problems for pop-
ulations of developing countries that have lower levels of 
educational achievement and income. Limited health care 
capacities and lack of social protection for large parts of the 
population mean that treatment and support for NCDs is 
often unavailable or catastrophically expensive [5,7]. In ad-
dition, NCDs have significant socioeconomic effects. Near-
ly a third of NCD deaths in LMICs occur below the age of 
60 [1]. These deaths at economically and socially produc-
tive ages have much wider consequences for these develop-
ing countries, with the loss of productivity and health sys-
tem expenditure becoming major barriers for national 
economic development and progress [5,8]. On individual 
or household levels, the sustained nature of NCDs and re-
sulting disabilities can lead to difficulties in working or seek-
ing employment. Additionally, the long–term care that 
NCDs require and the high cost of health care in many de-
veloping countries have major impacts on household in-
come, potentially leading to vicious cycles of poverty and 
illness [5]. The overall economic cost of NCDs cannot be 
understated: in India in 2004–2005, NCD health care ex-
penditure and total income lost due to these diseases was 
estimated to amount to 1% of its massive economy [3].
Despite the serious implications of the global NCD burden, 
it is only recently that determined policy action has been 
seen. The UN High–Level Meeting on NCDs in 2011 led 
the way for an international response, providing guidance 
on how to integrate NCD prevention and control across 
sectors and at all levels of government [1,3]. Furthermore, 
monitoring and surveillance capabilities of several high–
burden countries have shown an increased capacity in re-
cent years [2]. However, many of the recommended chang-
es – such as health care system reform towards sustainable 
universal care, and integration of NCD prevention into 
multi–sectoral responses – may take several years to imple-
ment, particularly in the LMICs that bear the brunt of the 
global NCD burden. Meanwhile it is essential that these re-
gions have reliable estimates of NCD burden to inform 
policy decisions with relevant evidence and help set appro-
priate health care and research priorities [9]. Transparent, 
up–to–date estimates of NCD burden allow monitoring of 
the diseases as well as evaluation of current policies, and 
are vital tools for planning policies and interventions to 
tackle the global NCD pandemic. This paper will attempt 
to address part of this need by carrying out a systematic 
literature review to estimate the prevalence of type 2 DM 
in Southern Asia.
Box 1 briefly reviews approaches to diagnosis and known 
risk factors for type 2 diabetes [10-18]. Table 1 displays 
current WHO diagnostic criteria for venous plasma for fast-
ing plasma glucose (FPG) and oral glucose tolerance test 
(OGTT). Diagnosis can be made through the use of either 
test alone or together. Specific values for capillary measure-
ments and whole blood have been provided in previous 
WHO publications as well [12]. In terms of geographic fo-
cus of this study, the UN's Southern Asia region is com-
prised of nine countries [19]. General information regard-
ing each country is given in Table 2, sourced from the 
World Bank online database [20]. The majority of South-
ern Asian countries are low or low–middle income coun-
tries [20]. The total population of the Southern Asia region 
comprises approximately 25% of the world total popula-
tion [20]. India was estimated to have the highest number 
of diabetic adults in 2000 [21] and 2010 [22], and both 
these studies predicted it would continue to have the high-
est number of diabetic adults by 2030. Pakistan and Ban-
gladesh were both estimated to be in the top ten as well. 
As such, an estimate of the diabetes prevalence for this re-
gion would provide a major insight into the global picture 
of diabetes burden.
This paper aims: (i) to contribute to the evidence base on 
type 2 diabetes mellitus in Southern Asia by systematically 
reviewing the relevant literature; (ii) to compare the preva-
lence estimates provided through different methods of di-
agnosing type 2 diabetes mellitus; (iii) to provide an assess-
ment of the role of urbanization on the burden of Type 2 
diabetes mellitus in the UN Southern Asia region based on 
the best available evidence; and (iv) to discuss the signifi-
cance of the regional estimate and the implications it may 
have on public health policy.
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METHODS
A systematic literature search of published studies provid-
ing population–based prevalence estimates of type 2 dia-
betes mellitus in Southern Asia was carried out. The online 
databases Medline and PubMed were searched, using the 
OVID search form for the Medline database and the default 
search engine for PubMed. Search terms for Medline and 
Box 1 Type 2 diabetes – diagnosis and risk factors
Type 2 diabetes mellitus (DM) is a metabolic disease characterised by persistent hyperglycaemia and disturbed carbohydrate, pro-
tein, and fat metabolism. It may present with combinations of typical symptoms such as polydipsia (increased thirst), polyphagia 
(excessive hunger), polyuria (increased passage of urine), glycosuria (glucose in urine), lethargy, and weight loss. These symptoms 
reflect the underlying DM pathophysiology of peripheral insulin resistance combined with inadequate pancreatic insulin secretion 
[10]. Many diabetic patients may be asymptomatic but in the long term uncontrolled hyperglycaemia can lead to severe compli-
cations such as diabetic retinopathy, neuropathy and nephropathy. Type 2 DM can be diagnosed through biochemical measure-
ments even if there are no presenting symptoms [11].
Under World Health Organisation (WHO) guidelines, there are currently two main diagnostic tests used to diagnose DM – the 
Fasting Plasma Glucose (FPG) test and the Oral Glucose Tolerance Test (OGTT) [11]. FPG involves measuring the level of glucose 
in a fasting (.8 hours without food) patient’s blood, often after an overnight fast. OGTT is also carried out on fasting patients and 
involves measurement of baseline blood glucose, followed by ingestion of 75g anhydrous glucose, and a subsequent blood glucose 
measurement after two hours to determine the efficacy with which glucose has been eliminated from the patient’s blood [12]. Al-
though WHO has also recently advocated the measurement of glycatedhaemoglobin (HbA1C) for diagnostic purposes [13], the 
stringent quality assurance tests required for its effective usage have limited its use in epidemiological studies to date. Additional 
notes on these diagnostic methods are provided in Online Supplementary Document.
The aetiology of type 2 DM is complex and likely involves a host of different factors, many of which are not fully understood. 
Common risk factors in the general population include older age, being overweight or obese, hypertension, leading an inactive 
lifestyle, smoking, and consuming an energy–dense diet [14,15]. Several of these risk factors may be considered ‘lifestyle’ factors 
that are potentially modifiable. However, a strong genetic component is also implicated in Type 2 DM, with relatives of diabetics 
at increased risk of developing it themselves, and certain ethnic populations believed to have increased susceptibility to diabetes 
[16,17]. South Asians in particular have been found to possess adverse body fat patterning that that may predispose to insulin re-
sistance [18], and have higher diabetes risk than Caucasians with equivalent body mass indices (BMI) [16]. This non–modifiable 
genetic susceptibility for South Asians means it is of even greater importance that policies address modifiable risk factors in order 
to tackle burgeoning diabetes prevalence in the region.
Table 1. World Health Organization's 2006 diagnostic criteria 
for type 2 diabetes
Fasting plasma glucose (FPG) ≥7.0mmol/L (126mg/dl)
and / or
2-hour plasma glucose (OGTT 2hPG) ≥11.1mmol/L (200mg/dl)
FPG –fasting plasma glucose, OGTT –oral glucose tolerance test.
Table 2. Southern Asia countries – selected characteristics
Country PoPulation, ×1000 
(2011)
life exPeCtanCy at birth 
(2010)
Gni Per CaPita
(uS$) (2011)
GDP uS$ Growth, % 
(2011)
total exPenDiture on health 
(% GDP) (2011)
PhySiCianS Per 1000 
PoPulation (2011)
Afghanistan 35 320 48 1140 +6% 9.6 0.210
Bangladesh 150 394 69  940 +7% 3.7 0.295
Bhutan 738 67 5570 +6% 4.1 0.023
India 1 241 492 65 3590 +7% 3.9 0.649
Iran 74 799 73 11 420† +2%† 5.8* 0.890
Maldives 320 77 7430 +7% 8.5 1.595
Nepal 30 486 68 1260 +4% 5.4 0.210†
Pakistan 176 745 65 2870 +3% 2.5 0.813
Sri Lanka 20 869 75 5520 +8% 3.4 0.492
GNI – gross national income, GDP – gross domestic product
*Data from 2009, most recent available data but likely inaccurate following punitive economic sanctions.
†Data from 2004.
PubMed are given in Table 3 and Table 4 respectively. Both 
Medical Subject Headings (MeSH terms) and keywords 
were used for the Medline search. The Medline search was 
more focused due to OVID’s Advanced Search feature, 
while the PubMed search was left broader in order to pick 
up a larger selection of studies. The final searches were car-
ried out on 13 February 2013. Box 2 shows inclusion cri-
teria, exclusion criteria and quality evaluation criteria.
Study selection
The literature search of online databases resulted in a total 
of 5653 studies: 1754 from Medline and 3899 from 
PubMed. After initial analysis of titles and abstracts, 402 
studies were selected that matched inclusion and exclusion 
criteria. 51 duplicate studies were removed and full texts 
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of the remaining 351 studies were further analysed and 
quality assessed. 39 studies were included in the final anal-
ysis, including 2 papers identified through reference lists 
of other assessed studies. A visual summary of the study 
selection process is presented in Figure 1.
Table 3. OVID Medline search terms
SearCh termS no. of StuDieS
1 Diabetes Mellitus, type 2/ 74 709
2 “adult–onset diabetes”.tw 358
3 (diabetes adj2 type 2).tw 54 707
4 “non–insulin dependent diabetes”.tw 8297
5 NIDDM.tw 67 32
6 Diabetes Mellitus/ or Diabetes Mellitus, type 2/ 155 830
7 1 OR 2 OR 3 OR 4 OR 5 OR 6 173 525
8 exp morbidity/ or exp mortality/ 563 526
9 incidence.tw 464 724
10 (prevalen* or mortality or epidemiol*).tw 961 509
11 Epidemiology/ 11 218
12 “cost of illness”/ 15 625
13 (burden adj2 diseas*).tw 7633
14 8 OR 9 OR 10 OR 11 OR 12 OR 13 1 586 465
15 Bangladesh/ or Bhutan/ or India/ or Afghanistan/ or Iran/ or Nepal/ or Pakistan/ or “Sri Lanka”/ 102 952
16 Indian Ocean Islands/ 568
17 (afghan* or bangladesh* or bengal* or bhutan* or iran* or india* or nepal* or pakistan* or maldiv* or srilanka *).tw 122 321
18 15 OR 16 OR 17 161 040
19 7 AND 14 AND 18 1896
20 Limit 19 to (humans and yr = ”1980–Current”) 1754 results
Table 4. PubMed search terms
SearCh termS no. StuDieS
Diabetes AND (Afghanistan OR Bangladesh OR 
Bhutan OR India OR Iran OR Maldives OR Nepal 
OR Pakistan OR Sri Lanka) AND (Epidemiology 
OR Incidence OR Prevalence OR Mortality)
3899 results
Figure 1. Study selection process. FPG –fasting plasma glucose, 
OGTT –oral glucose tolerance test.
Box 2 Literature search: Inclusion criteria, exclusion criteria and 
quality evaluation criteria
Inclusion criteria:
•   Population– or community–based study in a Southern 
Asian country providing prevalence estimates of type 2 di-
abetes mellitus based on primary data.
• All published study designs and all languages.
• Studies post–1980 with ≥200 participants.
• Studies looking at adults (≥20 years).
• S  tudies diagnosing diabetes through biochemical measure-
ments.
Exclusion criteria:
•   Studies investigating other forms of diabetes, such as ges-
tational diabetes or diabetes insipidus.
• Hospital– or clinic–based studies.
•   Studies diagnosing diabetes through self–reported ques-
tionnaires or symptoms only.
•   Study populations specifically predisposed to diabetes, 
such as relatives of known diabetics.
•   Studies investigating prevalence of complications in a dia-
betic cohort without commenting on actual prevalence of 
diabetes in area or community.
Quality evaluation criteria:
•   Diabetes diagnosed through fasting plasma glucose (FPG) 
after ≥8 hours fasting, and/or oral glucose tolerance test 
(OGTT) two hours after ingestion of 75g anhydrous glu-
cose or equivalent.
•   Appropriate diagnostic criteria for diabetes – most recent 
WHO  recommendations  of  FPG≥7.0mmol/L  and/or 
2hPG≥11.1mmol/L for venous plasma, or equivalent for 
other sample types. Stated whether blood samples were 
venous or capillary, and whether whole blood or plasma 
was analysed.
•   Clearly defined population recruited through representa-
tive sampling methods.
• Description of how known diabetics were accounted for.
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Data extraction
Titles and abstracts of all studies obtained through the da-
tabase searches were evaluated. Inclusion and exclusion 
criteria were applied. Basic details of all studies such as ti-
tle, authors, country, study year, year of publication, and 
sample size were extracted into an Excel spreadsheet for 
ease of full text evaluation. After initial extraction, full texts 
of the studies were analysed and assessed for quality crite-
ria. Quality assessment information is presented in Online 
Supplementary Document. Studies for which full text was 
not available were requested through inter–library loans. 
Duplicate studies were identified through study locations 
and matching sample sizes, and were removed. In addition, 
the reference lists of the selected studies were examined for 
relevant papers not captured by the literature search. These 
new studies were subsequently evaluated and added to the 
spreadsheet.
Another Excel spreadsheet was created for eligible studies 
selected through full text analysis. All the above data was 
extracted in addition to data on method of diagnosis; diag-
nostic criteria; specific location of the study; whether the 
study described the surveyed area as urban, rural, mixed 
or none; age range of participants and mean age if provid-
ed; diabetes prevalence in sample; and sex–specific sample 
size, mean age, and diabetes prevalence. Many studies 
looked at several different cohorts in various areas, often 
for purpose of comparison. These multiple cohorts were 
recorded separately so that individual sample characteris-
tics could be differentiated. Three separate sheets were cre-
ated for studies depending on their method of diagnosing 
new diabetes: one for studies that diagnosed diabetes on 
the basis of both FPG and OGTT results; one for studies 
using only FPG results; and one for studies using only 
OGTT results. These spreadsheets were the basis for prev-
alence estimation.
Data analysis
To allow for comparison between studies, all reported prev-
alence estimates were converted to prevalence/1000 popu-
lation through the equation:
Prevalence = Number of diabetes cases ×1000 / Sample size
During data modelling, the mean age, sample size, and 
age–specific prevalence estimates (per 1000 population) of 
all selected studies were used to create bubble graphs rep-
resenting the data. If this information was missing for par-
ticular cohorts, it was calculated from the data that was 
available, as detailed in Online Supplementary Docu-
ment. Several bubble graphs were created: for overall prev-
alence, sex–specific prevalence, urban/rural prevalence, 
and prevalence for specific diagnostic methods.
In order to calculate population prevalence estimates for 
the region, trend lines with the power function were com-
puted from the graphs to represent the relationship be-
tween age and prevalence for the selected data set. These 
were chosen because they had the highest r–squared (R2) 
values for these graphs and therefore accounted for the 
highest fraction of variance in the data. Statistical signifi-
cance (p–values) of differences observed through any com-
parisons was derived directly from the model. The result-
ing equations for overall combined prevalence, total male 
prevalence and total female prevalence were applied to 
2005 UNPD population estimates, the closest to the me-
dian study year of 2006 [23]. Prevalence results were mul-
tiplied by population figures for each age group, thereby 
giving an estimate of the total number of expected diabetes 
cases for each one. Totalling these up and taking a percent-
age of the total adult population allowed calculation of 
overall diabetes prevalence, for each sex separately and 
combined.
Study characteristics
Of the 39 studies included in the analysis, 15 studies diag-
nosed diabetes using both FPG and OGTT methods, 20 
solely using FPG, and 4 studies using OGTT only. Several 
studies looked at more than one cohort when estimating 
diabetes prevalence, often for purposes of comparison. A 
total of 57 cohorts were investigated by the 39 studies (Fig-
ure 2). During analysis each different cohort was repre-
sented independently. Within these cohorts, age–specific 
prevalence estimates were represented individually if avail-
able. Table 5 provides an overview of study characteristics 
by country. Population estimates are based on 2005 UNPD 
data [23].
The country with the largest number of studies, of all types, 
was by far India. It was also the only country for which 
suitable OGTT–only studies were available. No suitable 
studies of any kind were found in the literature search for 
Figure 2. Approximate geographic locations of the study 
cohorts. FPG –fasting plasma glucose, OGTT –oral glucose 
tolerance test.
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three countries: Afghanistan, Bhutan, and the Maldives. 
The remaining five countries had a mixture of FPG–only 
and FPG+OGTT combined studies, with the exception of 
Pakistan, for which only FPG studies were found. The 
mean study size was 5178, with samples ranging from 331 
to 25 969 participants. The median study year based on 
provided information was 2006 – while the earliest publi-
cation year was 1992, the earliest specified study year was 
1998 and the most recent study year was 2009. More in-
formation about the study cohorts is given in Table 6 and 
Table 7, and additional information is provided in Online 
Supplementary Document.
RESULTS
Figure 3 displays the relationship between mean age of 
sample and overall diabetes prevalence (both sexes com-
bined, all diagnostic methods). A total of 151 individual 
data points for age–specific prevalence were plotted from 
57 cohorts. 65 individual points were available from FPG 
and OGTT combined studies, 77 from FPG–only studies, 
and 9 from OGTT–only studies (Tables 8, 9 and 10). 
Age–specific prevalence data are provided in Online Sup-
plementary Document. Figure 3 shows a positive asso-
ciation between mean age and diabetes prevalence. Table 
11 illustrates this association using the trend line equa-
tion derived from overall prevalence results and also dis-
plays population prevalence estimates based on 2005 
UNPD estimates for the Southern Asia region. Based on 
these figures, the diabetes population prevalence for 2005 
was estimated to be 7.47%. The 50–54 age group had the 
highest proportion of the burden at 11.31%, and the 20–
24 group had the lowest proportion of the burden at 
4.64%. A total of 51.3% of the burden was seen in those 
aged 50 or more. The diabetes burden increases with age 
until the ages of 50 and 54, after which it decreases. This 
is due to the population age structure in 2005 –diabetes 
prevalence per 1000 population is shown to increase con-
tinuously with age.
Table 12 shows the overall prevalence equation applied to 
2010 UNPD population estimates, and Figure 4 compares 
the estimated numbers of diabetics between 2005 and 
2010. A higher overall prevalence estimate is observed for 
Table 5. Study characteristics by country
Country ProPortion of reGional aDult 
(≥20) PoPulation (%)
no. of fPG & oGtt 
CombineD StuDieS
no. of fPG–only StuDieS no. of oGtt–only 
StuDieS
total no. of StuDieS
Afghanistan 1.28 0 0 0 0
Bangladesh 8.65 2 2 0 4
Bhutan 0.04 0 0 0 0
India 73.24 9 8 4 21
Iran 4.78 2 2 0 4
Maldives 0.02 0 0 0 0
Nepal 1.53 1 2 0 3
Pakistan 8.97 0 4 0 4
Sri Lanka 1.49 1 2 0 3
Total 100.00 15 20 4 39
FPG – fasting plasma glucose, OGTT – oral glucose tolerance test
Table 6. Cohort characteristics by country
Country no. of fPG & 
oGtt CombineD 
CohortS
no. of fPG–
only CohortS
no. of 
oGtt–only 
CohortS
total no. of 
CohortS
Afghanistan 0 0 0 0
Bangladesh 2 3 0 5
Bhutan 0 0 0 0
India 20 9 6 35
Iran 2 2 0 4
Maldives 0 0 0 0
Nepal 1 2 0 3
Pakistan 0 4 0 4
Sri Lanka 1 5 0 6
Total 26 25 6 57
FPG – fasting plasma glucose, OGTT – oral glucose tolerance test
Table 7. General cohort characteristics
CharaCteriStiC
fPG & oGtt 
CombineD 
CohortS
fPG–only 
CohortS
oGtt–only 
CohortS
total
Rural 9 13 3 25
Urban 15 7 3 25
Both/None 2 5 0 7
Minimum size 526 331 588
Maximum size 12 514 25 969 1213
Mean size 3580 4126 954
FPG – fasting plasma glucose, OGTT – oral glucose tolerance test
Figure 3. The relationship between crude prevalence of type 2 
diabetes in Southern Asia and age.
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Table 8. Individual study prevalence data: FPG+OGTT combined studies
authorS Country urban/
rural
StuDy 
SamPle 
Size
aGe 
ranGe of 
PartiCi-
PantS
mean 
aGe
overall 
DiabeteS 
PrevalenCe 
(/1000 
PoPulation)
male 
DiabeteS 
PrevalenCe 
(/1000 
men)
mean 
aGe
Size of 
GrouP
female 
DiabeteS 
PrevalenCe 
(/1000 
women)
mean 
aGe
Size of 
GrouP
Bhowmik et al (2012) [24] Bangladesh Rural 2293 ≥20 50 79 90 43.9 842 71 40.4 1451
Rahim et al (2008) [25] Bangladesh Rural 3954 ≥20 37.1 70 75 39 1592 67 35.9 2375
Nazir et al (2012) [26] India Urban 2188 ≥20 38.7 158 – – – – – –
Prasad et al (2012) [27] India Urban 1178 20–80 45.6 157 178 47 590 138 44.2 588
Anjana et al (2011) [28] India Urban 1029 ≥20 50* 137 – – – – – –
Rural 2480 ≥20 50* 78 – – – – – –
Urban 1093 ≥20 50* 109 – – – – – –
Rural 2476 ≥20 50* 65 – – – – – –
Urban 840 ≥20 50* 135 – – – – – –
Rural 2051 ≥20 50* 30 – – – – – –
Urban 839 ≥20 50* 142 – – – – – –
Rural 2247 ≥20 50* 83 – – – – – –
Deepa et al (2011) [29] India Urban 526 ≥20 47.8 154 – – – – – –
Urban 596 ≥20 41.1 153 – – – – – –
Ravikumar et al (2011) [30] India Urban 2227 ≥20 42.7 157 – – – – – –
Ramachandran et al (2008) [31] India Urban 2192 ≥20 38.2 186 209 38.2† 1053 167 38.2† 1139
Urban 2290 ≥20 36.8 164 171 36.8† 988 159 36.8† 1302
Rural 2584 ≥20 38 92 104 38.0† 1280 80 38.0† 1304
Zargar et al (2008) [32] India Rural 3024 20–40 30.8 25 – – – – – –
Sadikot et al (2004) [33] India Urban 10 617 ≥25 44.8 59 56 44.5 5379 58 45.1 5238
Rural 7746 ≥25 44.2 25 25 44.1 3629 25 44.3 4117
Ramachandran et al (2001) [34] India Urban 11 216 ≥20 42.7 139 138 42.4 5288 140 43.0 5928
Hadaegh et al (2008) [35] Iran Urban 9489 ≥20 43.5 142 141 44.8 4006 143 42.4 5483
Sadeghi et al (2007) [36] Iran Both 12 514 ≥19 39 63 54 39† 6123 71 39† 6391
Shrestha et al (2006) [37] Nepal Urban 1012 ≥40 54.7 191 246 54.9‡ 423 151 54.5‡ 589
Katulanda et al (2008) [38] Sri Lanka Both 4388 ≥18 46.1 126 98 46.3 1720 109 46 2668
FPG – fasting plasma glucose, OGTT – oral glucose tolerance test
*Estimated mean age based on hypothetical maximum age of 80.
†Sex–specific mean ages not provided, overall mean age used for both sexes.
‡Estimated mean age based on age–group breakdowns.
Table 9. Individual study prevalence data: FPG–only studies
authorS Country urban/
rural
StuDy 
SamPle 
Size
aGe 
ranGe of 
PartiCi-
PantS
mean 
aGe
overall 
DiabeteS 
PrevalenCe 
(/1000 
PoPulation)
male 
DiabeteS 
PrevalenCe 
(/1000 
men)
mean aGe Size of 
GrouP
female 
DiabeteS 
PrevalenCe 
(/1000 
women)
mean 
aGe
Size of 
GrouP
Rahman et al (2007) [39] Bangladesh Rural 975 ≥20 38.9 85 94 41.7 360 80 37.3 615
Hussain et al (2005) [40] Bangladesh Rural 4757 ≥20 37.5 23 19 39.7† 2030 25 35.8* 2720
Urban 1555 ≥20 33.5 81 77 35.9* 731 85 31.4* 824
Pandey et al (2013) [41] India Rural 2616 35–70 46.7 43 – – – – – –
Urban 2008 35–70 48.4 151 – – – – – –
Vaz et al (2011) [42] India Rural 1266 ≥20 39 103 84 39† 609 120 39† 657
Rao et al (2010) [43] India Rural 1239 ≥30 51.3 160 188 50 434 144 52 805
Vijayakumar et al (2009) [44] India Rural 1645 ≥18 47.2 146 165 48.2 624 135 46.2 1021
Namperumalsamy et al (2009) [45] India Both 25969 ≥30 47 108 – – – – – –
Chow et al (2006) [46] India Rural 4538 ≥30 46.8 132 – – – – – –
Gupta et al (2003) [47] India Both 1091 ≥20 43.9 123 132 43.3 532 115 44.4 559
Misra et al (2001) [48] India Urban 532 ≥18 35.4 103 112 37.8 170 99 34.3 362
Esteghamati et al (2009) [49] Iran Both 3397 25–64 44.2 87 – – – – – –
Azimi–Nezhad et al (2008) [50] Iran Both 3438 20–64 48.5 55 – – – – – –
Sharma et al (2011) [51] Nepal Both 14008 ≥20 41.4 63 81 41.4† 5326 53 41.4† 8682
Paudyal et al (2008) [52] Nepal Rural 1475 ≥40 54.7 41 – – – – – –
Basit et al (2011) [53] Pakistan Rural 1264 ≥25 42.3 142 165 43.5 424 131 41.7 840
Zafar et al (2011) [54] Pakistan Urban 1091 12–80 36 131 154 36† 293 123 36† 798
Mahar et al (2010) [55] Pakistan Urban 19211 30–90 42 87 – – – – – –
Basit et al (2002) [56] Pakistan Rural 2032 ≥25 38.9 72 119 40.4 670 49 38.1 1362
Pinidiyapathirage et al (2013) [57] Sri Lanka Urban 2986 35–64 52.3 247 233 52.2† 1349 259 52.3† 1637
Wijewardene et al (2005) [58]
Sri Lanka
Urban 4301 30–65 46.8 175 183 46.4 1891 168 47.2 2410
Rural 571 30–65 44.6 175 73 44.7 275 67 44.6 297
Rural 331 30–65 45.9 48 50 45.4 139 47 46.3 192
Rural 844 30–65 45.7 71 70 45.6 387 72 45.8 457
FPG – fasting plasma glucose
*Estimated mean age based on age–group breakdowns.
†Sex–specific mean ages not provided, overall mean age used for both sexes.
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2010 than for 2005: 7.60% compared to 7.47%. Figure 5 
and Table 13 illustrate the relationship between diabetes 
prevalence and age for males (all diagnostic methods). 
Based on the trend line equations, male prevalence is slight-
ly higher than female prevalence at all ages. At the extreme, 
estimated male prevalence for the 70–79 age group is 
336.08 per 1000, whereas female prevalence is 297.57 per 
1000. Figure 6 and Table 14 illustrate female age–specif-
ic prevalence for all diagnostic methods. Sex– and age–spe-
cific prevalence data are presented in Supplementary On-
line Document.
Table 10. Individual study prevalence data: OGTT–only studies
authorS Country urban/
rural
StuDy 
SamPle 
Size
aGe ranGe 
of PartiCi-
PantS
mean 
aGe
overall DiabeteS 
PrevalenCe (/1000 
PoPulation)
male DiabeteS 
PrevalenCe 
(/1000 men)
mean 
aGe
Size of 
GrouP
female DiabeteS 
PrevalenCe 
(/1000 women)
mean 
aGe
Size of 
GrouP
Boddula et al (2008) [59] India Urban 1112 ≥30 55* 246 284 55* 557 207 55* 555
Ramachandran et al (2004) [60] India Rural 1213 ≥20 41 63 74 41.8 497 56 40.5 716
Ramachandran et al (1994) [61] India Urban 873 ≥60 70* 237 – – – – – –
Rural 588 ≥60 70* 99 – – – – – –
Ramachandran et al (1992) [62] India Urban 900 ≥20 38 82 103 40 457 61 37 443
Rural 1038 ≥20 41 24 27 41 520 21 41 518
OGTT – oral glucose tolerance test
*Estimated mean age based on hypothetical maximum age of 80.
Table 11. Overall prevalence estimates for 2005
aGe 
ranGe
mean 
aGe 
(yearS)
PrevalenCe / 
1000 PoPulation 
(y = 0.0368x2.039)
2005 
unPD 
PoPulation 
eStimateS 
( × 1000)
CalCulateD 
2005 
PrevalenCe 
eStimateS 
( × 1000)
ProPortion 
of burDen 
by aGe 
GrouP (%)
20–24 22 20.09 152 031 3055 4.64
25–29 27 30.51 134 001 4088 6.21
30–34 32 43.14 115 491 4982 7.57
35–39 37 58.00 102 984 5973 9.07
40–44 42 75.10 89 614 6730 10.22
45–49 47 94.46 76 802 7255 11.02
50–54 52 116.09 64 131 7445 11.31
55–59 57 139.98 47 010 6581 9.98
60–64 62 166.16 37 303 6198 9.41
65–69 67 194.63 29 394 5721 8.69
70–74 72 225.40 20 538 4629 7.03
75–79 77 258.47 12 348 3191 4.85
Total: 881 647 65 848 100.00
2005 population 
prevalence:7.47%
UNPD– United Nations Population Division
Figure 5. Relationship between crude prevalence of type 2 
diabetes and age in Southern Asia in male examinees.
Table 12. Overall prevalence estimates for 2010
aGe 
ranGe
mean 
aGe 
(yearS)
PrevalenCe / 
1000 PoPulation 
(y = 0.0368x2.039)
2010  
unPD 
PoPulation 
eStimateS 
( × 1000)
CalCulateD 
2010 Preva-
lenCe eStimateS 
( × 1000)
ProPortion 
of burDen by 
aGe GrouP 
(%)
20–24 22 20.09 163 363 3282 4.36
25–29 27 30.51 149 024 4546 6.04
30–34 32 43.14 131 390 5668 7.53
35–39 37 58.00 112 937 6550 8.70
40–44 42 75.10 100 399 7540 10.01
45–49 47 94.46 86 776 8197 10.89
50–54 52 116.09 73 608 8545 11.35
55–59 57 139.98 60 318 8444 11.21
60–64 62 166.16 42 750 7103 9.43
65–69 67 194.63 32 320 6291 8.35
70–74 72 225.40 23 627 5325 7.07
75–79 77 258.47 14 742 3810 5.06
Total: 991 254 75 302 100.00
2010 population prevalence: 7.60%
UNPD– United Nations Population Division
Table 13. Male prevalence estimates for 2005
aGe ranGe mean 
aGe 
(yearS)
Preva-
lenCe/1000 men 
(y = 0.0208x2.2308)
2005 
unPD male 
PoPulation 
eStimateS 
( × 1000)
CalCulateD 
2005 male 
PrevalenCe 
eStimateS 
( × 1000)
ProPor-
tion of 
burDen by 
aGe GrouP 
(%)
20–24 22 20.55 78 574 1614 4.07
25–29 27 32.45 69 157 2244 5.66
30–34 32 47.40 59 699 2830 7.14
35–39 37 65.53 53 302 3493 8.81
40–44 42 86.94 46 349 4029 10.17
45–49 47 111.73 39 741 4440 11.21
50–54 52 140.00 32 984 4618 11.65
55–59 57 171.82 23 669 4067 10.26
60–64 62 207.27 18 546 3844 9.70
65–69 67 246.42 14 386 3545 8.95
70–74 72 289.34 9985 2889 7.29
75–79 77 336.08 5979 2009 5.07
Total: 452 371 39 622 100.00
2005 male prevalence: 8.76%
2005 corrected prevalence: 7.72%
UNPD– United Nations Population Division
Figure 4. Estimated numbers of type 2 diabetes cases in 
Southern Asia (in thousands) by age group in 2005 and 2010.
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Table 14. Female prevalence estimates for 2005
aGe 
ranGe
mean 
aGe 
(yearS)
PrevalenCe/1000 
women 
(y = 0.0239x2.1708)
2005 unPD 
female 
PoPulation 
eStimateS 
( × 1000)
CalCulateD 
2005 female 
PrevalenCe 
eStimateS 
(1000)
ProPortion 
of burDen 
by aGe 
GrouP
20–24 22 19.61 73 457 1441 4.10%
25–29 27 30.59 64 844 1984 5.65%
30–34 32 44.24 55 792 2468 7.03%
35–39 37 60.62 49 682 3012 8.58%
40–44 42 79.83 43 265 3454 9.84%
45–49 47 101.90 37 061 3777 10.76%
50–54 52 126.91 31 147 3953 11.26%
55–59 57 154.90 23 341 3616 10.30%
60–64 62 185.92 18 757 3487 9.93%
65–69 67 220.01 15 008 3302 9.41%
70–74 72 257.21 10 553 2714 7.73%
75–79 77 297.57 6368 1895 5.40%
Total: 429 275 35 102 100.00%
2005 female prevalence: 8.18%
2005 corrected prevalence: 7.20%
UNPD– United Nations Population Division
Figure 6. Relationship between crude prevalence of type 2 
diabetes and age in Southern Asia in female examinees.
The crude population prevalence estimate for males in 
2005 is 8.76% (39 622 000 cases), and for females is 8.18% 
(35 102 000 cases) (P < 0.001). These do not total the com-
bined prevalence estimate of 65 848 000 cases (7.47%) 
since several studies did not provide enough data to calcu-
late male and female age–specific prevalence, only enough 
to calculate combined sexes age–specific prevalence. To ac-
count for this incomplete data, the combined prevalence 
estimate was used as an envelope and a correction factor 
of 0.881 was applied to male and female prevalence esti-
mates. Resultantly, the adjusted 2005 population preva-
lence estimates are 7.72% for males and 7.20% for females. 
Figure 7 illustrates a comparison between corrected male 
and female prevalence estimates at 5–year age intervals.
Urban and rural residency
32 out of the 39 selected studies (50 out of 57 cohorts) 
specifically defined their study population as residing in an 
urban area or a rural area. Incidentally, out of the reporting 
studies, 25 cohorts were specified as urban and 25 as rural. 
Figure 8 illustrates diabetes prevalence against age in ur-
ban cohorts (both sexes, all diagnostic methods), and Fig-
ure 9 does likewise for rural cohorts. Table 15 and Figure 
10 highlight the prevalence differences observed between 
urban and rural cohorts. Figure 11 compares prevalence 
of diabetes in urban males with prevalence in rural males. 
Figure 12 compares prevalence of urban and rural females. 
In both cases urban residency is associated with signifi-
Figure 7. Male and female prevalence of type 2 diabetes in 
Southern Asia in 2005, adjusted to an “envelope” defined by all 
studies with prevalence data.
Figure 8. Crude prevalence of type 2 diabetes in Southern Asia 
in urban regions and its relationship with age.
Figure 9. Crude prevalence of type 2 diabetes in Southern Asia 
in rural regions and its relationship with age.
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cantly higher diabetes prevalence (P < 0.001). Figures 13 
and 14 show the estimates for both sexes by residency. In-
dividual bubble graphs for residency are presented in On-
line Supplementary Document.
Table 15. Urban and rural overall prevalence comparison 
(P < 0.001)
aGe (yearS) eStimateD urban PrevalenCe/1000 
PoPulation (y = 0.053x2.0206)
eStimateD rural PrevalenCe/1000 
PoPulation (y = 0.0917x1.7091)
20 22.55 15.34
25 35.40 22.47
30 51.16 30.68
35 69.86 39.93
40 91.50 50.17
45 116.08 61.36
50 143.62 73.46
55 174.12 86.46
60 207.59 100.32
65 244.03 115.03
70 283.45 130.56
75 325.86 146.90
Figure 10. Comparison of the prevalence of type 2 diabetes in 
Southern Asia by age in urban and rural regions – both sexes 
included.
Figure 11. Comparison of the prevalence of type 2 diabetes in 
Southern Asia by age in urban and rural regions – men only.
Figure 12. Comparison of the prevalence of type 2 diabetes in 
Southern Asia by age in urban and rural regions – women only.
Figure 13. Male and female prevalence of type 2 diabetes in 
Southern Asia based on information from urban regions.
Figure 14. Male and female prevalence of type 2 diabetes in 
Southern Asia based on information from rural regions.
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Method of diabetes diagnosis
Figure 15 shows the relationship between age and diabe-
tes prevalence when only considering studies that utilised 
both FPG and OGTT in diagnosing diabetes. Figure 16 
shows the relationship for studies that used only FPG, and 
Figure 17 shows OGTT–only studies. 65 age–specific data 
points were used to calculate the FPG+OGTT trend line, 
77 data points used to calculate the FPG–only trend line, 
but due to the small number of available OGTT studies 
only 9 age–specific data points were used in calculating the 
OGTT trend line. Figure 18 compares the estimated prev-
alence using each of the three diagnostic methods. The 
combined FPG plus OGTT studies resulted in a higher 
population prevalence estimate than FPG–only studies 
when applied to UNPD figures, as shown by Table 16 and 
Table17. FPG plus OGTT studies result in a population 
prevalence of 7.75%, while FPG–only studies result in a 
prevalence of 7.32%. The small number of OGTT–only 
studies predicted a population prevalence of 6.95%, as 
shown in Table 18.
Table 16. Prevalence estimates for 2005 based on FPG+OGTT 
studies
aGe 
ranGe
mean 
aGe 
(yearS)
PrevalenCe/1000 
PoPulation 
(y = 0.0181x2.2319)
2005 unPD 
PoPulation 
eStimateS 
( × 1000)
CalCu-
lateD 2005 
PrevalenCe 
eStimateS 
( × 1000)
ProPortion 
of burDen 
by aGe 
GrouP (%)
20–24 22 17.94 152 031 2727 3.99
25–29 27 28.34 134 001 3797 5.56
30–34 32 41.40 115 491 4782 7.00
35–39 37 57.25 102 984 5895 8.63
40–44 42 75.96 89 614 6807 9.96
45–49 47 97.64 76 802 7499 10.97
50–54 52 122.36 64 131 7847 11.48
55–59 57 150.18 47 010 7060 10.33
60–64 62 181.18 37 303 6759 9.89
65–69 67 215.42 29 394 6332 9.27
70–74 72 252.96 20 538 5195 7.60
75–79 77 293.86 12 348 3629 5.31
Total: 881 647 68 330 100.00
FPG+OGTT population 
prevalence: 7.75%
Overall population prevalence 
(2005): 7.47%
FPG – fasting plasma glucose, OGTT – oral glucose tolerance test, UNPD– 
United Nations Population Division
Figure 15. Relationship between crude prevalence of type 2 
diabetes and age in Southern Asia based on the studies using 
FPG+OGTT in their case definition. FPG – fasting plasma 
glucose, OGTT – oral glucose tolerance test.
Figure 16. Relationship between crude prevalence of type 2 
diabetes and age in Southern Asia based on the studies using 
FPG only in their case definition. FPG – fasting plasma glucose.
Table 17. Prevalence estimates for 2005 based on FPG–only studies
aGe 
ranGe
mean 
aGe 
(yearS)
PrevalenCe/1000 
PoPulation 
(y = 0.1021x1.7684)
2005 unPD 
PoPulation 
eStimateS 
( × 1000)
CalCu-
lateD 2005 
PrevalenCe 
eStimateS 
( × 1000)
ProPortion of 
burDen by aGe 
GrouP
20–24 22 24.15 152 031 3672 5.69%
25–29 27 34.69 134 001 4649 7.20%
30–34 32 46.85 115 491 5411 8.38%
35–39 37 60.57 102 984 6237 9.66%
40–44 42 75.78 89 614 6791 10.52%
45–49 47 92.46 76 802 7101 11.00%
50–54 52 110.56 64 131 7090 10.98%
55–59 57 130.05 47 010 6114 9.47%
60–64 62 150.90 37 303 5629 8.72%
65–69 67 173.08 29 394 5088 7.88%
70–74 72 196.58 20 538 4037 6.25%
75–79 77 221.36 12 348 2733 4.23%
Total: 88  647 64 553 100.00%
FPG–only population prevalence: 
7.32%
Overall population prevalence 
(2005): 7.47%
FPG – fasting plasma glucose, UNPD– United Nations Population Division
Table 18. Prevalence estimates for 2005 based on OGTT–only 
studies
aGe 
ranGe
mean 
aGe 
(yearS)
PrevalenCe/1000 
PoPulation 
(y = 0.033x2.1118)
2005 unPD 
PoPulation eSti-
mateS ( × 1000)
CalCu-
lateD 2005 
PrevalenCe 
eStimateS 
( × 1000)
ProPor-
tion of 
burDen by 
aGe GrouP
20–24 22 8.52 152 031 1295 2.11
25–29 27 15.74 134 001 2109 3.44
30–34 32 26.21 115 491 3026 4.94
35–39 37 40.51 102 984 4172 6.81
40–44 42 59.25 89 614 5309 8.66
45–49 47 83.03 76 802 6377 10.41
50–54 52 112.44 64 131 7211 11.77
55–59 57 148.09 47 010 6962 11.36
60–64 62 190.58 37 303 7109 11.60
65–69 67 240.51 29 394 7070 11.54
70–74 72 298.47 20 538 6130 10.00
75–79 77 365.07 12 348 4508 7.36
Total: 881,  647 61 278 100.00
OGTT–only population prevalence: 
6.95%
Overall population prevalence 
(2005): 7.47%
OGTT – oral glucose tolerance test, UNPD– United Nations Population Division
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DISCUSSION
This study provides the most up–to–date transparent esti-
mation of diabetes prevalence in the UN Southern Asia re-
gion, building upon previous studies looking at prevalence 
in comparable regions or in specific constituent countries 
[21,22,63,64]. It is also, to our knowledge, the first study 
to transparently estimate diabetes prevalence and trends in 
Southern Asia by synthesizing findings from numerous 
community–based studies in addition to broader national 
population studies.
A transparent systematic literature review of two online da-
tabases was carried out. Pre–defined inclusion and quality 
criteria narrowed down 39 studies from an initial 5653 re-
sults. Search terms were specified, and quality assessment 
criteria for selected studies were provided in Appendices. 
Enough studies were captured for estimation of overall di-
abetes prevalence, male and female prevalence, and urban 
and rural prevalence for each sex. Study cohort sites had a 
wide geographic distribution within the countries that were 
analysed, as shown in Figure 2. Additionally there was an 
even split of rural and urban studies, allowing for compar-
ison of prevalence in both demographics. Data was not 
captured from all countries in the Southern Asia region –
the systematic literature review did not find any suitable 
studies from Afghanistan, Bhutan, or the Maldives. How-
ever, Table 5 shows that these three countries have the 
smallest adult populations in the region. For all other coun-
tries, including the three most populous countries of India, 
Pakistan, and Bangladesh, suitable numbers of geographi-
cally dispersed studies were identified. While this paper 
was able to adequately meet most of its set objectives, the 
small number of OGTT–only studies captured in the search 
meant that all recognised diagnostic methods could not be 
fully compared in terms of prevalence estimates, and so this 
objective was only partially met.
By applying this study’s prevalence estimates to UNPD pop-
ulation Figures [23], the overall diabetes prevalence for the 
Southern Asia region was estimated to be 7.47% for 2005, 
and 7.60% for 2010. Although the reviewed studies were 
more representative of the year 2005, it is interesting to 
note the effects of an ageing population on diabetes preva-
lence. Estimates indicate that 25.0% of the regional popu-
lation was aged 50 or older in 2010, compared to 23.9% 
in 2005. In addition, UNPD projections for Southern Asia 
predict that total population and life expectancy at birth 
for both males and females will continue to rise in the re-
gion over the next 30 years [23]. The findings of this study 
suggest that as the population continues to age in the fu-
ture, the overall burden of diabetes in Southern Asia will 
also continue to increase, and that concerted policy action 
is needed to facilitate the response to this increased burden.
It was found that diabetes prevalence was consistently high-
er for males than for females. The burden was highest in the 
50–54 age group for both sexes, and within this age group 
there was a 9.35% difference between estimated male and 
female prevalence. Prevalence/1000 population continued 
to increase with age for both sexes but due to the popula-
tion age structure the burden attributed to older age groups 
was progressively smaller after the ages of 50–54. After cor-
rection for missing data, the 2005 population prevalence 
estimate for males was 7.72%, and for females was 7.20%. 
This translates into an estimated 34 915 000 male and 
30 933 000 female diabetics in Southern Asia in 2005.
This study found that urban residency was strongly associ-
ated with higher diabetes prevalence for both sexes. The 
observed difference is noteworthy – past the age of 55 the 
urban prevalence was estimated to be more than twice the 
rural prevalence. Although males had higher prevalence 
than females in both urban and rural settings, the differ-
ence was noticeably smaller in urban cohorts than rural 
cohorts: a 6.03% difference between urban males and fe-
males, but a 16.74% difference between their rural coun-
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Figure 17. Relationship between crude prevalence of type 2 
diabetes and age in Southern Asia based on the studies using 
OGTT only in their case definition. OGTT –oral glucose 
tolerance test.
Figure 18. Comparison of the relationship between crude 
prevalence of type 2 diabetes and age in Southern Asia 
depending on the diagnostic methods used to establish case 
definition.V
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terparts. Higher rates of diabetes among urban residents 
may be explained through increases in physical inactivity 
and consumption of high sugar and fat diets – both strong 
risk factors for diabetes – that have become synonymous 
with urban lifestyles. Mohan suggested that diabetes rates 
in India are quickly escalating because of the rapid urban-
isation that is sweeping the country [17]. Conversely, rural 
prevalence remains lower because of limited exposure to 
these risk factors and maintenance of traditional physical-
ly vigorous rural lifestyles.
Sufficient numbers of FPG–only and FPG+OGTT com-
bined studies were identified to allow comparison between 
these two diagnostic methods. The small number of 
OGTT–only studies also provided interesting trends. Over-
all the differences between these methods appeared to be 
minimal. The higher prevalence estimates of FPG+OGTT 
compared to FPG–only were to be expected since the for-
mer used an additional diagnostic method. FPG–only stud-
ies estimated higher diabetes prevalence at younger ages 
(<52) and lower prevalence at older ages (>52) compared 
to OGTT–only. Combined FPG+OGTT prevalence esti-
mates lay in between the FPG and OGTT estimates at both 
ends of the age spectrum. In addition, FPG–only studies 
estimated the highest burden proportion to be at a young-
er age – in the 45–49 age group – followed by a small de-
crease in the 50–54 age group. FPG+OGTT studies and the 
limited number of OGTT–only studies found highest bur-
den proportion in the 50–54 age group. These findings 
suggest that FPG may have greater sensitivity at younger 
ages, while OGTT may be more sensitive to diabetes in 
older age.
This study’s prevalence estimates were primarily based on 
trend line equations obtained by plotting study size, mean 
age and prevalence estimates on bubble graphs. Bubble 
graphs accommodate gaps in data better than weighted 
mean box–plots, and the resultant trend lines can be used 
to estimate the expected prevalence for any given age rath-
er than just the specific age group means. Therefore, bub-
ble graphs are preferable over weighted mean box–plots 
when considering a disease such as diabetes, for which the 
steady prevalence increase with age has previously been 
well established [21]. The trend lines obtained in this study 
all had high R2 values – specified on each graph for pur-
poses of transparency – indicating that they were represen-
tative of the data and took into account a high degree of 
variance.
Several of this study’s findings are in line with previous es-
timations of diabetes burden in comparable regions. Esti-
mates for 2000 [21] and 2010 [22] both suggest that in 
developing countries, diabetes burden is highest between 
the ages of 40 and 64, and lowest under the age of 40. This 
was reflected in the findings. Wild and colleagues also 
found that global diabetes prevalence was higher overall 
for males than females. However, more recent estimates for 
Southern Asia found no distinct increase in diabetes risk 
with male gender [64]. This study found a small but con-
sistent difference between male and female prevalence. 
Based on national surveys for countries in the region, Jay-
wardena and colleagues estimated the overall Southern 
Asia diabetes prevalence to be in the range of 4.5–10.3% 
for the period 1995–2006[64]. This study’s estimate of 
7.47% for 2005 falls in the middle of this range. Addition-
ally, this study’s 2010 prevalence estimate of 7.60% is sim-
ilar to the findings of Shaw and colleagues for the WHO 
region of South–East Asia[22], a geographic region that in-
cludes six out of the nine countries of the UN Southern 
Asia region (all apart from Afghanistan, Iran and Pakistan). 
Recent IDF estimations suggest that diabetes prevalence 
may be even higher – at an estimated 8.60% for South–East 
Asia in 2011 [65]. However, it is difficult to make compar-
isons between estimates for the UN Southern Asia region 
and the WHO South–East Asia region. In addition, differ-
ent studies often use widely varying methods for study se-
lection and estimating prevalence, contributing to the ob-
served inconsistencies. Nevertheless, a substantial body of 
evidence including this study indicate that the diabetes 
burden in this area of the world is large and growing.
Limitations
This systematic review considered published studies from 
1980–2013. However, suitable studies were only identified 
for the period 1992–2013. Not looking at studies prior to 
1980 may have excluded viable studies, but older studies 
often used previous diabetes diagnostic criteria which un-
derestimated prevalence. Most of the identified studies car-
ried out prior to 1990 used the old 1980/1985 WHO cri-
teria with the higher FPG cut–off of 7.8mmol/L for 
diabetes diagnosis. Including such studies in the analysis 
would distort the prevalence estimate because of the dif-
fering diabetes case definitions.
Several recent studies did not detail the diagnostic criteria 
used to identify diabetics, despite explaining their method 
of diagnosis. These studies were excluded to ensure that 
the case definition of diabetes in the selected studies re-
mained constant. Other studies did not make it clear 
whether the biochemical samples they used were venous 
or capillary, or whether whole blood or plasma was anal-
ysed. WHO provides diagnostic guidelines for each of these 
sample types [11,12], but when sample type was not spec-
ified the study was excluded to minimise case definition 
misclassifications. Adherence to these stringent quality as-
sessment criteria potentially limited the number of studies 
that could be included in this analysis. In addition, studies 
that did not diagnose diabetes through biochemical mea-
surements but instead used techniques such as self–report-
ed surveys were also excluded. Several studies had found 
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low knowledge of diabetes in Southern Asia, even in dia-
betic patients [66,67], and therefore such methods were 
considered unreliable.
Studies investigating other forms of diabetes such as gesta-
tional diabetes or diabetes insipidus were excluded. These 
studies were easy to identify because of the specific nature 
of gestational diabetes, and the different clinical presenta-
tion of diabetes insipidus to diabetes mellitus (DM). How-
ever, a major limitation of this paper was the inadequate 
ability to distinguish between type 1 DM and type 2 DM. 
Many risk factors for type 2 DM, such as diet and physical 
inactivity, are modifiable and therefore may be amenable 
to policy intervention, but there are no known preventa-
tive measures against type 1 DM. Most analysed studies did 
not further investigate identified diabetics to exclude type 
1 DM, meaning that this study’s findings may be an over-
estimation of the prevalence of type 2 DM. However, in the 
adult age range that was being investigated, type 2 DM is 
more common than type 1 DM, hence their previous names 
of “adult–onset diabetes mellitus” and “childhood–onset 
diabetes mellitus”. In addition, it has been noted that while 
type 1 DM rarely causes death by ketoacidosis in developed 
countries, sufferers in many developing countries may un-
fortunately have a radically shortened lifespan due to lim-
ited insulin availability which is crucial for type 1 DM man-
agement [68]. This may hold true especially for some of 
the poor rural areas investigated in this study. As a result, 
any error in the prevalence estimate due to type 1 diabet-
ics is likely to be small.
Only published studies were reviewed. The resulting anal-
ysis may have suffered from publication bias as the re-
viewed papers may only show those studies in which sig-
nificant results were found. Publication bias may have 
prevented studies that did not show significant diabetes 
prevalence from being published in the first place, prevent-
ing these studies from being captured in this review. While 
no limits were set on language, time constraints also pre-
vented translation and therefore inclusion of non–English 
studies. This may have resulted in exclusion of viable non–
English studies. However, even without setting language 
limits, only a very small number of non–English studies 
were identified by the literature search. This might be due 
to the status of English as an official language in several ex–
colonial countries in the Southern Asia region, most nota-
bly India and Pakistan.
No suitable studies were identified for three out of nine of 
the countries in the region – Afghanistan, Bhutan, and the 
Maldives. As mentioned, however, these are the least pop-
ulous countries in the region, and combined only account 
for 1.34% of the regional adult population. Nevertheless it 
is a noteworthy limitation that no data was available for 
these countries when the estimated regional population 
prevalence took their populations into account as well. An-
other limitation arose when comparing urban and rural 
studies. Cohorts were classified as urban or rural on the 
basis of individual study descriptions. No standardised def-
initions of ‘urban’ or ‘rural’ were used, meaning there may 
be discrepancies between different studies on their cohort 
classification.
Not all selected studies provided male and female sex–spe-
cific prevalence breakdowns, while others did not provide 
sample sizes for sex–specific prevalence or did not report 
mean age. This limited the number of cohorts that could 
be analysed for male and female age–specific prevalence. 
Where possible, sample sizes were calculated based on re-
ported number of cases and corresponding prevalence fig-
ures. However, this study’s findings were limited by as-
sumptions that had to be made to account for incomplete 
data. UNPD national age structures were applied where ap-
propriate [23]. This method of estimation may have in-
creased imprecision as study populations are not necessar-
ily representative of the national average. The use of a 
correction factor to account for incomplete sex–specific 
data may have been another source of imprecision. A hy-
pothetical maximum age of 80 was used to calculate mean 
age for studies that provided no maximum age range. This 
assumption was made as this was the highest age used in 
reviewed studies that included a maximum age, and also 
because the minority of studies that looked at participants 
aged 80+ had very small sample sizes for those age groups. 
In addition, the 2005 UNPD population estimates for 
Southern Asia suggest that the 80+ age group accounts for 
only 0.58% of the population, so this was not considered 
a major limitation.
While every effort was made to ensure accuracy and the 
use of systematic methods, human error may have resulted 
in accidental exclusion of relevant studies when inclusion 
and quality criteria were being applied. Having only one 
person review and evaluate studies is a potential limitation 
of this study design. Using several independent evaluators 
to select studies, with a suitable method for resolving dis-
putes, may increase reliability of the study’s findings.
Implications for policy
Evidence on disease burden is essential for countries to 
plan and develop programs in response to the NCD pan-
demic. The WHO 2008–2013 Action Plan for the Preven-
tion and Control of Noncommunicable Diseases highlight-
ed that before prevention and control policies can be 
implemented, one of the first steps is to assess the burden 
of disease [69]. Engelgau and colleagues also proposed a 
framework for policy decision–making on NCDs[7], and 
improved surveillance is an essential component of their 
initial assessment stage. Several Southern Asian countries 
have shown improvements in their national NCD surveil-
lance and monitoring capabilities in the last decade [2]. 
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However, as previously discussed, estimates of diabetes 
burden vary widely between different sources. Further im-
provements in national surveillance capabilities are needed 
so that authoritative and standardised estimations of the 
burden of NCDs can be made. Accurate and up–to–date 
estimations of burden are also important in evaluation of 
current policies, programs, and of health system capacity. 
A number of policies have shown promise – in 2003 India 
enacted The Cigarette and Other Tobacco Products Act 
which is considered to have effectively reduced the public’s 
exposure to tobacco smoke, through advertisement, and 
minors’ access to cigarettes [7]. India also recently launched 
a pilot phase of the National Programme for Prevention and 
Control of Diabetes, Cardiovascular Diseases and Stroke 
(NPDCS), and has made financing commitments for the 
near future [70]. The aims of this program are laudable but 
monitoring of such programmes is necessary to ensure re-
sources are used efficiently, and that appropriate targets and 
priorities are set [7]. This is of special importance due to 
rapidly–changing nature of NCDs and the many challeng-
es that governments of developing Southern Asian coun-
tries face when attempting to deal with them.
The findings of this study suggest that future urbanisation 
and increased life expectancy will lead to a substantial rise 
in the burden of type 2 DM in the Southern Asia region. 
Commentators have noted that the process of population 
ageing currently being observed in developing countries is 
different to the demographic transition that occurred in 
developed countries several decades ago. In particular, the 
current demographic transition in developing countries has 
occurred on a faster scale than in developed countries, and 
without the associated improvements in living conditions, 
social provisions, and access to health care [7]. This has led 
to a ‘compressed timeline’ for developing countries to 
mount effective responses to growing NCD burdens com-
pared to what developed countries had [1]. ‘Unhealthy age-
ing’ in Southern Asia due to these lagging improvements 
in nutrition and socioeconomic conditions is predicted to 
add to the natural increases in disease burden expected of 
an ageing population [7]. Therefore it is paramount that 
both prevention and treatment policy options are consid-
ered – the root causes of NCDs need to be addressed, and 
health system capacity should be reviewed to deal with the 
increasing burden.
Prevention efforts for diabetes can come in many forms, but 
there are several that may be especially relevant to Southern 
Asia. Before any successful prevention policies can be imple-
mented it is important that knowledge and awareness re-
garding diabetes is improved in the general population. 
Many studies have shown that in Southern Asian popula-
tions, awareness of diabetes and its risk factors is poor 
[71,72], even among diabetic patients [66,67]. Population–
level education and health promotion schemes should be 
put into place to improve awareness of the risk factors for 
diabetes and the other main NCDs. Diabetes has many life-
style–modifiable risk factors, and by improving knowledge 
regarding these, the Southern Asian population can be em-
powered to pursue healthier lifestyle choices. Increased risk 
factor awareness and the resulting community empower-
ment have been seen to have a positive effect in the past. 
Mohan and colleagues reported that following such efforts, 
an Indian community was prompted to create a public park 
with their own funds which resulted in significant improve-
ments in physical activity levels for local resident[73].
Departure from traditional dietary patterns and the uptake 
of diets high in saturated fats and heavily refined carbohy-
drates are believed to be important underlying factors in 
rising rates of obesity and diabetes in Southern Asia [17]. 
In particular, low intake of fibre, mono– and poly–unsatu-
rated fats, and high consumption of refined carbohydrates, 
saturated fats and trans–fats have been identified as prob-
lematic dietary habits leading to insulin resistance in South-
ern Asian populations [74]. Policies should focus on ad-
dressing these unhealthy dietary patterns with a view to 
inform and educate. Successful policies from the health 
sector may include efforts to improve food labelling 
through dialogue with food companies, which when com-
bined with education on NCD dietary risk factors may go 
some way to lowering diabetes and obesity incidence [7]. 
Focus should also be given on encouraging people to 
switch from traditional high trans–fat cooking oils such as 
ghee and vanaspati to poly–unsaturated alternatives [74].
The health sector has an important role to play in the man-
agement and treatment of NCDs. Table 2 shows that while 
all the Southern Asian economies are growing, many of 
them spend very small proportions of their gross domestic 
product (GDP) as health expenditure. In 2001, the WHO 
Commission on Macroeconomics and Health found that a 
basic set of essential health interventions costs approxi-
mately US$34 per capita, believed to be a modest sum even 
for low–income countries [75]. However, several Southern 
Asian countries spend less on health than even this recom-
mended minimum per capita expenditure [20]. NCDs un-
dermine economic progress and have significant macroeco-
nomic and microeconomic impacts [76]. The increasing 
burden of NCDs will strain existing health systems if health 
expenditure is not increased. Physician density is also low 
in many Southern Asian countries; Engelgau and colleagues 
suggest that improving region–wide health education and 
training capacities may help fill human resource gaps across 
the region by taking advantage of economies of scale [7].
Even if health system capacities are expanded to deal with 
the increasing burden of NCDs, access to appropriate 
health care remains a major challenge across the Southern 
Asia region. Studies in several Southern Asian countries 
have found significant personal expenditure and substan-
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tial financial loss associated with paying for diabetes treat-
ment, with the main costs being the direct expenses of in-
vestigation, treatment, and hospital admission [49,77,78]. 
These expensive out–of–pocket medical costs are a major 
barrier for universal access to health care services in South-
ern Asia, and result in widening inequalities between rich 
and poor. In addition to increasing health care capacity, 
Southern Asian countries should aim to improve access to 
health care by implementing WHO universal coverage re-
forms [79]. Successful policy strategies may involve im-
proving revenue collection by targeting tax avoidance; 
pooling risk to reduce cost–sharing; efficiency savings from 
introducing Health Technologies Assessment (HTA); and 
simply increasing the priority given to health and thereby 
increasing governmental health expenditure.
Implications for future research
Following the recent WHO addendum approving the use 
of HbA1c as a diagnostic method [1], WHO and American 
Diabetes Association diagnostic guidelines and criteria are 
mostly aligned. Future studies investigating prevalence in 
a population or community should use these standardised 
methods and criteria for diagnosing diabetes to allow for 
informative comparison between studies. The utilisation of 
HbA1c measurements also presents new avenues for diabe-
tes epidemiological research. If appropriate quality assur-
ance measures are put in place, as per WHO recommenda-
tions, HbA1c presents a valuable method for investigating 
long term changes in glycaemic status in study subjects.
Studies calculating overall prevalence inadvertently calcu-
late male and female prevalence as well, but as seen in this 
paper, in many cases these were not reported. Additionally 
many studies failed to report basic information such as 
mean age of sample, age group of sample, type of biochem-
ical sample taken, or diagnostic criteria used to define dia-
betes. Access to this information would reduce the number 
of assumptions that have to be made for incomplete data, 
and additionally would allow for a more accurate estimate 
as far fewer studies would have to be excluded from analy-
sis. As awareness of the need for large–scale population es-
timates of NCDs becomes more commonplace, it is hoped 
authors carrying out community–based studies begin to 
employ common standards to allow effective utilisation of 
their work in burden of disease analyses.
Diabetes is one end of a spectrum of glycaemic states, and 
future studies could estimate the burden of different forms 
of prediabetes as well. Impaired fasting glucose (IFG) and 
impaired glucose tolerance (IGT) are diagnosed with FPG 
and OGTT respectively so many studies report their prev-
alence alongside diabetes. Regional estimation of the bur-
den of both prediabetes as well as diabetes would allow for 
a more comprehensive analysis of the challenges these hy-
perglycaemic diseases pose.
This study found that diabetes is strongly associated with 
urban residency in Southern Asia. As the region continues 
a process of rapid globalisation and urbanisation, it is im-
portant to maintain diabetes surveillance in both urban and 
rural cohorts. Urban migration and the increasing accessi-
bility of inactive, sedentary lifestyles suggest that the dia-
betes burden will increase in the future. Projections for 
2030 predict that several Southern Asian nations will con-
tinue to rank among the countries with the largest numbers 
of diabetic residents [21,22]. However, monitoring and 
analysis of these vulnerable populations can inform public 
health policymakers and help manage the burden of dia-
betes. It is important that future studies focus on high–risk 
populations: urban residents, and, as life expectancy in-
creases, the growing number of elderly people as well.
CONCLUSION
This systematic literature review found a high prevalence 
of type 2 DM in the Southern Asia region. Diabetes preva-
lence was associated with male gender, and strongly asso-
ciated with older age and urban residency. On the basis of 
these findings this study also predicted that diabetes prev-
alence will continue to increase in the future as life expec-
tancy in the region rises and countries continue to undergo 
processes of urbanisation. The findings of this study were 
consistent with several past studies, but dissimilar to the 
results of others. This highlights that inconsistent surveil-
lance and conflicting estimations of burden are some of the 
many challenges faced by the Southern Asia region and its 
constituent countries in their effort to respond to the rising 
burden of NCDs.
Accurate and up–to–date estimates of burden of disease are 
essential for planning of policies, target and priority setting, 
as well as monitoring and assessment of existing programs. 
However, greater standardisation and shared principles are 
needed across different studies so that strong, clear mes-
sages are given to policymakers. It is hoped that improved 
surveillance capabilities in Southern Asian countries will 
encourage common standards for prevalence estimation to 
be established.
While current policies and programs on diabetes control 
have met with some success, the region faces numerous 
hurdles. Rising life expectancies coupled with ‘unhealthy’ 
ageing present a new set of challenges to those faced by de-
veloped countries several decades ago. Policies focusing on 
prevention have to deal with a population that largely has 
little awareness of diabetes and its risk factors, and is be-
coming increasingly accustomed to a sedentary lifestyle 
and unhealthy eating patterns. Health sectors also have 
their own set of issues – total health expenditure is low in 
many Southern Asian countries, there are significant hu-
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man resource gaps, and already struggling health systems 
are predicted to be put under even greater strain as diabe-
tes prevalence continues to increase. In addition, from an 
equity perspective, high cost–sharing coupled with the 
long–term care needed for NCDs such as diabetes means 
that access to health care may be limited for a large propor-
tion of people in the region.
However, despite these numerous policy challenges and 
the projected increase in diabetes prevalence, slow progress 
is being made. NCDs are at the forefront of the interna-
tional health agenda, several Southern Asian countries have 
greatly improved their NCD surveillance and monitoring 
capacities, and the numbers of studies estimating burden 
of type 2 diabetes mellitus appears to be increasing in re-
cent years. Greater attention needs to be paid to this disease 
and its risk factors on national and regional levels in South-
ern Asia so that the growing burden of diabetes can be ad-
equately addressed in the future.V
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